Logo image
HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia
Journal article   Open access   Peer reviewed

HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia

Qianze Dong, Yan Xiu, Yang Wang, Christina Hodgson, Nick Borcherding, Craig Jordan, Jane Buchanan, Eric Taylor, Brett Wagner, Mariah Leidinger, …
Nature communications, Vol.13(1), pp.6107-6107
10/16/2022
DOI: 10.1038/s41467-022-33861-1
PMCID: PMC9573868
PMID: 36245043
url
https://doi.org/10.1038/s41467-022-33861-1View
Published (Version of record) Open Access

Abstract

Acute myeloid leukemia (AML) is maintained by self-renewing leukemic stem cells (LSCs). A fundamental problem in treating AML is that conventional therapy fails to eliminate LSCs, which can reinitiate leukemia. Heat shock transcription factor 1 (HSF1), a central regulator of the stress response, has emerged as an important target in cancer therapy. Using genetic Hsf1 deletion and a direct HSF1 small molecule inhibitor, we show that HSF1 is specifically required for the maintenance of AML, while sparing steady-state and stressed hematopoiesis. Mechanistically, deletion of Hsf1 dysregulates multifaceted genes involved in LSC stemness and suppresses mitochondrial oxidative phosphorylation through downregulation of succinate dehydrogenase C (SDHC), a direct HSF1 target. Forced expression of SDHC largely restores the Hsf1 ablation-induced AML developmental defect. Importantly, the growth and engraftment of human AML cells are suppressed by HSF1 inhibition. Our data provide a rationale for developing efficacious small molecules to specifically target HSF1 in AML.
Cell Self Renewal - genetics Heat Shock Transcription Factors - genetics Heat Shock Transcription Factors - metabolism Humans Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - metabolism Neoplastic Stem Cells - metabolism Succinate Dehydrogenase - metabolism Transcription Factors - genetics Transcription Factors - metabolism

Details

Logo image